| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Abdel Rahman Tahan | |
| Abu Bakr Madani | |||
| Hussien Qahtani | |||
| Jihad Inshasi | |||
| Peter Rieckmann | |||
| Saeed Bohlega | |||
| P2860 | cites work | Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis | Q28246535 |
| Consanguinity decreases risk of breast cancer--cervical cancer unaffected | Q34462385 | ||
| Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group | Q34511062 | ||
| Defining the response to interferon-β in relapsing-remitting multiple sclerosis patients | Q57601974 | ||
| Multiple sclerosis in Saudi Arabia | Q68298453 | ||
| The cost of delaying treatment in multiple sclerosis: what is lost is not regained | Q74096735 | ||
| Epidemiology of multiple sclerosis in Kuwait: new trends in incidence and prevalence | Q81698829 | ||
| Familial multiple sclerosis: does consanguinity have a role? | Q82991794 | ||
| Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study | Q34515400 | ||
| Effect of early versus delayed interferon beta-1b treatment on disability after a first clinical event suggestive of multiple sclerosis: a 3-year follow-up analysis of the BENEFIT study | Q34581641 | ||
| Compared benefit of approved and experimental immunosuppressive therapeutic approaches in multiple sclerosis | Q34630494 | ||
| Vitamin d deficiency- an ignored epidemic. | Q34747450 | ||
| Early treatment and dose optimisation BENEFIT and BEYOND. | Q36260729 | ||
| The cardiac effects of mitoxantrone: do the benefits in multiple sclerosis outweigh the risks? | Q36407273 | ||
| Glatiramer acetate: mechanisms of action in multiple sclerosis | Q36832932 | ||
| Vitamin D treatment in multiple sclerosis | Q37528781 | ||
| Multiple sclerosis: current treatment algorithms. | Q37866036 | ||
| Prevalence of multiple sclerosis in Dubai, United Arab Emirates | Q39977793 | ||
| Pattern of presentation of multiple sclerosis in Saudi Arabia: analysis based on clinical and paraclinical features. | Q50885566 | ||
| P275 | copyright license | Creative Commons Attribution 2.0 Generic | Q19125117 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple sclerosis | Q8277 |
| P304 | page(s) | 2959-63 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | Multiple sclerosis in the Arabian Gulf countries: a consensus statement | |
| P478 | volume | 260 |
| Q47434874 | Age-Period-Cohort Modeling of Multiple Sclerosis Incidence Rates in Kuwait: 1980-2014. |
| Q92314304 | An Overview of the Intrinsic Role of Citrullination in Autoimmune Disorders |
| Q92841431 | Assessment of the Burden of Multiple Sclerosis Patients' Caregivers in Saudi Arabia |
| Q55439494 | Clinical Presentations and Phenotypic Spectrum of Multiple Sclerosis at a University Hospital in Saudi Arabia. |
| Q47327274 | Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia |
| Q47324100 | Depression, anxiety and stress severities in multiple sclerosis patients using injectable versus oral treatments |
| Q34607780 | Differential upregulation of the hypothetical transmembrane protein 66 (TMEM66) in multiple sclerosis patients with potential inflammatory response |
| Q55343128 | Environmental exposures and the risk of multiple sclerosis in Saudi Arabia. |
| Q64064876 | Epidemiology of multiple sclerosis in Iran: A systematic review and meta-analysis |
| Q91672723 | Four novel mutations in the mitochondrial ND4 gene of complex I in patients with multiple sclerosis |
| Q37424282 | Future of management of multiple sclerosis in the middle East: a consensus view from specialists in ten countries |
| Q47843189 | HLA class II polymorphism in Saudi patients with multiple sclerosis |
| Q44014309 | Increasing prevalence and incidence rates of multiple sclerosis in Kuwait. |
| Q38645029 | MS People's Performance and Satisfaction With Daily Occupations: Implications for Occupational Therapy |
| Q64075118 | Macular ganglion cell complex parameters by optical coherence tomography in cases of multiple sclerosis without optic neuritis compared to healthy eyes |
| Q33896817 | Multiple sclerosis-A disease on a dramatically rising trend in Iran: Review of possible reasons |
| Q35093103 | Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring |
| Q41002202 | Orthodontic treatment for a patient with multiple sclerosis |
| Q28607748 | Prevalence and Incidence of Multiple Sclerosis in Fars Province, Southern Iran |
| Q26864418 | Review of the pharmacoeconomics of early treatment of multiple sclerosis using interferon beta |
| Q89608526 | Rising prevalence of multiple sclerosis in Saudi Arabia, a descriptive study |
| Q58804013 | Sociodemographic, environmental and lifestyle risk factors for multiple sclerosis development in the Western region of Saudi Arabia. A matched case control study |
| Q49893202 | Stroke and seizure continue to be the major brunt of in patient neurology care. An observation from teaching hospital |
| Q26780466 | Update in vitamin D and multiple sclerosis |
| Q37297647 | ZFAT gene variant association with multiple sclerosis in the Arabian Gulf population: A genetic basis for gender-associated susceptibility |
Search more.